Brainsway (BWAY) has released an update.
BrainsWay Ltd., a leader in noninvasive neurostimulation treatments for mental health, is expanding its Deep TMS platform in the U.S. East Coast with a new order of 14 devices from a significant mental health network. This move reinforces BrainsWay’s growing presence in the mental health sector and aligns with its strategy to build strong relationships with health groups for sustainable growth. The company already boasts an installed base of 1,215 systems and continues to innovate in the TMS space with multiple FDA-cleared indications.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
